Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm
Data from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; ClinicalTrials.gov; NCT00882336) was used to assess the proportions of patients aged 50–65 years free of diabetes and not receiving lipid-lowering therapy (LLT) considered to be at low (
Gespeichert in:
| Veröffentlicht in: | European journal of preventive cardiology 2015-02, Vol.22 (2), p.200-202 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 202 |
|---|---|
| container_issue | 2 |
| container_start_page | 200 |
| container_title | European journal of preventive cardiology |
| container_volume | 22 |
| creator | Halcox, Julian P Tubach, Florence Sazova, Ogün Sweet, Stephen Medina, Jesús |
| description | Data from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; ClinicalTrials.gov; NCT00882336) was used to assess the proportions of patients aged 50–65 years free of diabetes and not receiving lipid-lowering therapy (LLT) considered to be at low ( |
| doi_str_mv | 10.1177/2047487313507680 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652396926</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2047487313507680</sage_id><sourcerecordid>1652396926</sourcerecordid><originalsourceid>FETCH-LOGICAL-c379t-e864e21aa2adfd40d77ec99e46a44449a1ac4058f3ea792ed7db191caf0085843</originalsourceid><addsrcrecordid>eNp1kM1q3TAQhUVJaEKSfVdFy2zcSrJsSctyuW0KgUJ-1mYijW-U2pYjWYFAFn2NvF6fpLrcJItCZjPD8J0zzCHkE2dfOFfqq2BSSa1qXjdMtZp9IIfbVSW15ntvs6oPyElKd6xUy4TQ-iM5EJIZoVVzSJ4u0A6Qku-9hcWHiYaernMMM8JE57LCaUl__zxTC9H58ADJ5gEijT79pjn5aUOXW6R5drCgo5ePacGxyCxdhRgmiI_0YouuH2DIuwswbEL0y-14TPZ7GBKevPQjcv19fbU6q85__fi5-nZe2VqZpULdShQcQIDrnWROKbTGoGxBljLAwUrW6L5GUEagU-6GG26hZ0w3WtZH5HTnO8dwnzEt3eiTxWGACUNOHW8bUZvWiLagbIfaGFKK2Hdz9GP5ouOs28be_R97kXx-cc83I7o3wWvIBah2QIINdnchx6l8-77hP1NsjaU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652396926</pqid></control><display><type>article</type><title>Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Halcox, Julian P ; Tubach, Florence ; Sazova, Ogün ; Sweet, Stephen ; Medina, Jesús</creator><creatorcontrib>Halcox, Julian P ; Tubach, Florence ; Sazova, Ogün ; Sweet, Stephen ; Medina, Jesús ; EURIKA steering committee</creatorcontrib><description>Data from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; ClinicalTrials.gov; NCT00882336) was used to assess the proportions of patients aged 50–65 years free of diabetes and not receiving lipid-lowering therapy (LLT) considered to be at low (<1%), intermediate (1% to <5%) and high (≥5%) 10-year risk of cardiovascular mortality according to the Systematic Coronary Risk Evaluation (SCORE) algorithm and the updated algorithm that considers patients’ total cholesterol and high-density lipoprotein cholesterol (HDL-C) levels as independent variables (SCORE-HDL). Of 2321 patients analysed, 19.3%, 60.7% and 20.0% were considered to be at low, intermediate and high cardiovascular risk respectively according to SCORE, and 25.7%, 57.2% and 17.1% respectively according to SCORE-HDL. Thus, there was an overall trend towards reclassification from higher to lower risk categories when SCORE-HDL was compared with SCORE.</description><identifier>ISSN: 2047-4873</identifier><identifier>EISSN: 2047-4881</identifier><identifier>DOI: 10.1177/2047487313507680</identifier><identifier>PMID: 24092875</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Aged ; Algorithms ; Body Mass Index ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - classification ; Cardiovascular Diseases - mortality ; Cholesterol - blood ; Cholesterol, HDL - blood ; Europe - epidemiology ; Female ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors</subject><ispartof>European journal of preventive cardiology, 2015-02, Vol.22 (2), p.200-202</ispartof><rights>The European Society of Cardiology 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</rights><rights>The European Society of Cardiology 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c379t-e864e21aa2adfd40d77ec99e46a44449a1ac4058f3ea792ed7db191caf0085843</citedby><cites>FETCH-LOGICAL-c379t-e864e21aa2adfd40d77ec99e46a44449a1ac4058f3ea792ed7db191caf0085843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/2047487313507680$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/2047487313507680$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21819,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24092875$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Halcox, Julian P</creatorcontrib><creatorcontrib>Tubach, Florence</creatorcontrib><creatorcontrib>Sazova, Ogün</creatorcontrib><creatorcontrib>Sweet, Stephen</creatorcontrib><creatorcontrib>Medina, Jesús</creatorcontrib><creatorcontrib>EURIKA steering committee</creatorcontrib><title>Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm</title><title>European journal of preventive cardiology</title><addtitle>Eur J Cardiovasc Prev Rehabil</addtitle><description>Data from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; ClinicalTrials.gov; NCT00882336) was used to assess the proportions of patients aged 50–65 years free of diabetes and not receiving lipid-lowering therapy (LLT) considered to be at low (<1%), intermediate (1% to <5%) and high (≥5%) 10-year risk of cardiovascular mortality according to the Systematic Coronary Risk Evaluation (SCORE) algorithm and the updated algorithm that considers patients’ total cholesterol and high-density lipoprotein cholesterol (HDL-C) levels as independent variables (SCORE-HDL). Of 2321 patients analysed, 19.3%, 60.7% and 20.0% were considered to be at low, intermediate and high cardiovascular risk respectively according to SCORE, and 25.7%, 57.2% and 17.1% respectively according to SCORE-HDL. Thus, there was an overall trend towards reclassification from higher to lower risk categories when SCORE-HDL was compared with SCORE.</description><subject>Aged</subject><subject>Algorithms</subject><subject>Body Mass Index</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - classification</subject><subject>Cardiovascular Diseases - mortality</subject><subject>Cholesterol - blood</subject><subject>Cholesterol, HDL - blood</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><issn>2047-4873</issn><issn>2047-4881</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1q3TAQhUVJaEKSfVdFy2zcSrJsSctyuW0KgUJ-1mYijW-U2pYjWYFAFn2NvF6fpLrcJItCZjPD8J0zzCHkE2dfOFfqq2BSSa1qXjdMtZp9IIfbVSW15ntvs6oPyElKd6xUy4TQ-iM5EJIZoVVzSJ4u0A6Qku-9hcWHiYaernMMM8JE57LCaUl__zxTC9H58ADJ5gEijT79pjn5aUOXW6R5drCgo5ePacGxyCxdhRgmiI_0YouuH2DIuwswbEL0y-14TPZ7GBKevPQjcv19fbU6q85__fi5-nZe2VqZpULdShQcQIDrnWROKbTGoGxBljLAwUrW6L5GUEagU-6GG26hZ0w3WtZH5HTnO8dwnzEt3eiTxWGACUNOHW8bUZvWiLagbIfaGFKK2Hdz9GP5ouOs28be_R97kXx-cc83I7o3wWvIBah2QIINdnchx6l8-77hP1NsjaU</recordid><startdate>20150201</startdate><enddate>20150201</enddate><creator>Halcox, Julian P</creator><creator>Tubach, Florence</creator><creator>Sazova, Ogün</creator><creator>Sweet, Stephen</creator><creator>Medina, Jesús</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150201</creationdate><title>Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm</title><author>Halcox, Julian P ; Tubach, Florence ; Sazova, Ogün ; Sweet, Stephen ; Medina, Jesús</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c379t-e864e21aa2adfd40d77ec99e46a44449a1ac4058f3ea792ed7db191caf0085843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Algorithms</topic><topic>Body Mass Index</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - classification</topic><topic>Cardiovascular Diseases - mortality</topic><topic>Cholesterol - blood</topic><topic>Cholesterol, HDL - blood</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Halcox, Julian P</creatorcontrib><creatorcontrib>Tubach, Florence</creatorcontrib><creatorcontrib>Sazova, Ogün</creatorcontrib><creatorcontrib>Sweet, Stephen</creatorcontrib><creatorcontrib>Medina, Jesús</creatorcontrib><creatorcontrib>EURIKA steering committee</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of preventive cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Halcox, Julian P</au><au>Tubach, Florence</au><au>Sazova, Ogün</au><au>Sweet, Stephen</au><au>Medina, Jesús</au><aucorp>EURIKA steering committee</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm</atitle><jtitle>European journal of preventive cardiology</jtitle><addtitle>Eur J Cardiovasc Prev Rehabil</addtitle><date>2015-02-01</date><risdate>2015</risdate><volume>22</volume><issue>2</issue><spage>200</spage><epage>202</epage><pages>200-202</pages><issn>2047-4873</issn><eissn>2047-4881</eissn><abstract>Data from the European Study on Cardiovascular Risk Prevention and Management in Usual Daily Practice (EURIKA; ClinicalTrials.gov; NCT00882336) was used to assess the proportions of patients aged 50–65 years free of diabetes and not receiving lipid-lowering therapy (LLT) considered to be at low (<1%), intermediate (1% to <5%) and high (≥5%) 10-year risk of cardiovascular mortality according to the Systematic Coronary Risk Evaluation (SCORE) algorithm and the updated algorithm that considers patients’ total cholesterol and high-density lipoprotein cholesterol (HDL-C) levels as independent variables (SCORE-HDL). Of 2321 patients analysed, 19.3%, 60.7% and 20.0% were considered to be at low, intermediate and high cardiovascular risk respectively according to SCORE, and 25.7%, 57.2% and 17.1% respectively according to SCORE-HDL. Thus, there was an overall trend towards reclassification from higher to lower risk categories when SCORE-HDL was compared with SCORE.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>24092875</pmid><doi>10.1177/2047487313507680</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2047-4873 |
| ispartof | European journal of preventive cardiology, 2015-02, Vol.22 (2), p.200-202 |
| issn | 2047-4873 2047-4881 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1652396926 |
| source | MEDLINE; SAGE Complete A-Z List; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
| subjects | Aged Algorithms Body Mass Index Cardiovascular Diseases - blood Cardiovascular Diseases - classification Cardiovascular Diseases - mortality Cholesterol - blood Cholesterol, HDL - blood Europe - epidemiology Female Humans Male Middle Aged Risk Assessment Risk Factors |
| title | Reclassification of European patients’ cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithm |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A04%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reclassification%20of%20European%20patients%E2%80%99%20cardiovascular%20risk%20using%20the%20updated%20Systematic%20Coronary%20Risk%20Evaluation%20algorithm&rft.jtitle=European%20journal%20of%20preventive%20cardiology&rft.au=Halcox,%20Julian%20P&rft.aucorp=EURIKA%20steering%20committee&rft.date=2015-02-01&rft.volume=22&rft.issue=2&rft.spage=200&rft.epage=202&rft.pages=200-202&rft.issn=2047-4873&rft.eissn=2047-4881&rft_id=info:doi/10.1177/2047487313507680&rft_dat=%3Cproquest_cross%3E1652396926%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652396926&rft_id=info:pmid/24092875&rft_sage_id=10.1177_2047487313507680&rfr_iscdi=true |